SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-006374
Filing Date
2022-04-29
Accepted
2022-04-29 14:50:43
Documents
6
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220609xdef14a.htm DEF 14A 967244
2 GRAPHIC tmb-20220609xdef14a001.jpg GRAPHIC 10297
3 GRAPHIC tmb-20220609xdef14a016.jpg GRAPHIC 67046
4 GRAPHIC tmb-20220609xdef14a015.jpg GRAPHIC 82344
5 GRAPHIC tmb-20220609xdef14a002.jpg GRAPHIC 7911
6 GRAPHIC tmb-20220609xdef14a004.jpg GRAPHIC 7936
  Complete submission text file 0001558370-22-006374.txt   1210794
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36464 | Film No.: 22874149
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences